콘텐츠로 건너뛰기
Merck
  • Depsipeptide substrates for sortase-mediated N-terminal protein ligation.

Depsipeptide substrates for sortase-mediated N-terminal protein ligation.

Nature protocols (2014-01-11)
Daniel J Williamson, Michael E Webb, W Bruce Turnbull
초록

Technologies that allow the efficient chemical modification of proteins under mild conditions are widely sought after. Sortase-mediated peptide ligation provides a strategy for modifying the N or C terminus of proteins. This protocol describes the use of depsipeptide substrates (containing an ester linkage) with sortase A (SrtA) to completely modify proteins carrying a single N-terminal glycine residue under mild conditions in 4-6 h. The SrtA-mediated ligation reaction is reversible, so most labeling protocols that use this enzyme require a large excess of both substrate and sortase to produce high yields of ligation product. In contrast, switching to depsipeptide substrates effectively renders the reaction irreversible, allowing complete labeling of proteins with a small excess of substrate and catalytic quantities of sortase. Herein we describe the synthesis of depsipeptide substrates that contain an ester linkage between a threonine and glycolic acid residue and an N-terminal FITC fluorophore appended via a thiourea linkage. The synthesis of the depsipeptide substrate typically takes 2-3 d.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
1,4-Dioxane, ACS reagent, ≥99.0%, contains ≤25 ppm BHT as stabilizer